Evidence map›Paper›PMID 41860670›Full record

ReviewMolecular biology reports2026

microRNA-155: a versatile noncoding RNA.

P Shaik Syed Ali, Md Parwez Ahmad, K M Huria Parveen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

P Shaik Syed AliSchool of Medicine, The Maldives National University, Male', Maldives. shaik.syed@mnu.edu.mv.
Md Parwez AhmadSchool of Medicine, The Maldives National University, Male', Maldives.
K M Huria ParveenSchool of Medicine, The Maldives National University, Male', Maldives.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are ~ 22-nucleotide-long noncoding RNAs that regulate gene expression at the post-transcriptional level through mRNA cleavage or translational repression. To date, approximately 2,700 mature human miRNAs have been identified, although biological functions have been assigned to fewer than 600. Among these, miR-155 has emerged as a regulatory miRNA with important roles in metabolism, immune homeostasis, and disease pathogenesis. Dysregulated miR-155 expression has been implicated in metabolic disorders, including diabetes and preeclampsia, as well as autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. Mechanistic and preclinical evidence indicates that aberrant miRNA-155 expression contributes to tumorigenesis by modulating tumor suppressor genes in hematologic malignancies and solid tumors. This review summarizes the current updates on the physiological and pathological roles of miRNA-155.

Indexed as

MicroRNAsAnimalsAutoimmune DiseasesGene Expression RegulationGene Expression Regulation, NeoplasticHumansMetabolic DiseasesNeoplasmsMicroRNAsMIRN155 microRNA, humanAutoimmune diseaseCancerMetabolic disordersmicroRNAmiRNA155

Identifiers

PMID41860670

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.